This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Barry Greene
President at Alnylam Pharmaceuticals


Barry Greene, President of Alnylam, joined in 2003 and brings over 25 years of experience in healthcare. Prior to Alnylam, he was General Manager of Oncology at Millennium Pharmaceuticals, where he led the company’s global strategy and execution for its oncology business, culminating in the successful approval and launch of VELCADE™(bortezomib).

Agenda Sessions

  • Crossing the Barriers and Boundaries II: Towards Global Approval for Onpattro and other RNAi Therapeutics